GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Suheung Co 008490.KS · KRW

Health Care · KRX · 🇰🇷 South Korea

Compare

17,700

+0.91%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩722.31bn

FY2016FY2025

Net income

₩43.49bn

FY2016FY2025

Free cash flow

₩29.61bn

FY2016FY2025

Shareholders' equity

₩488.68bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩722.31bn₩653.26bn₩594.57bn₩634.97bn₩596.73bn₩553.01bn₩460.73bn₩393.48bn₩350.01bn₩340.36bn
Gross profit₩170.05bn₩103.23bn₩138.05bn₩137.28bn₩164.42bn₩155.32bn₩121.20bn₩100.95bn₩97.49bn₩72.45bn
Research and development₩9.48bn₩7.85bn₩7.03bn₩7.38bn₩7.11bn₩6.02bn₩4.89bn₩4.47bn₩4.06bn₩3.75bn
Operating income₩68.58bn₩33.84bn₩42.99bn₩61.98bn₩69.60bn₩74.32bn₩47.40bn₩39.31bn₩37.29bn₩40.11bn
Net income₩43.49bn₩18.28bn₩6.12bn₩33.98bn₩53.69bn₩53.00bn₩31.72bn₩25.74bn₩23.08bn₩27.31bn
Diluted earnings per share3,911.171,643.64550.333,056.424,828.554,766.492,852.672,196.031,919.952,360.40

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩1.06trn₩1.02trn₩993.74bn₩926.42bn₩809.95bn₩765.99bn₩708.86bn₩639.10bn₩595.29bn₩585.89bn
Total liabilities₩520.12bn₩509.92bn₩516.67bn₩456.69bn₩380.09bn₩389.01bn₩379.87bn₩330.93bn₩294.45bn₩297.45bn
Debt₩143.76bn₩124.57bn₩74.01bn₩172.57bn₩137.50bn₩116.72bn₩321.19bn₩273.39bn₩245.63bn₩251.16bn
Shareholders' equity₩488.68bn₩454.68bn₩425.67bn₩421.34bn₩387.76bn₩338.06bn₩295.61bn₩273.61bn₩269.91bn₩258.89bn
Shares outstanding11m11m11m11m11m11m11m12m12m12m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩76.86bn₩56.16bn₩10.49bn₩52.91bn₩66.85bn₩46.09bn₩22.12bn₩49.01bn₩45.69bn₩53.03bn
Capital spending−₩47.26bn−₩38.71bn−₩52.26bn−₩64.18bn−₩38.14bn−₩52.19bn−₩47.54bn−₩60.66bn−₩46.57bn−₩38.47bn
Free cash flow₩29.61bn₩17.46bn−₩41.77bn−₩11.27bn₩28.71bn−₩6.09bn−₩25.43bn−₩11.65bn−₩882.1m₩14.57bn
Dividends paid−₩7.37bn−₩2.83bn−₩4.45bn−₩5.56bn−₩7.30bn−₩5.02bn−₩10.47bn−₩5.43bn−₩5.53bn−₩3.15bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩212.90bn₩201.55bn₩166.40bn₩185.05bn₩190.02bn₩180.84bn₩148.57bn₩166.59bn
Gross profit₩42.62bn₩48.38bn₩39.91bn₩34.08bn₩38.04bn₩38.35bn₩22.86bn₩24.89bn
Operating income₩22.49bn₩21.24bn₩9.28bn₩13.71bn₩28.83bn₩13.11bn₩3.37bn₩7.43bn
Net income₩13.71bn₩11.81bn₩4.64bn₩8.98bn₩23.94bn₩5.93bn₩618.7m₩10.64bn
Diluted earnings per share1,233.091,062.40417.15807.822,153.13533.0655.64957.31
Cash from operations₩34.53bn₩18.22bn₩9.29bn₩24.39bn₩20.11bn₩23.07bn₩13.10bn₩9.74bn
Capital spending−₩13.09bn−₩11.89bn−₩17.81bn−₩11.81bn−₩11.85bn−₩5.78bn−₩9.95bn−₩11.69bn
Free cash flow₩21.45bn₩6.33bn−₩8.52bn₩12.59bn₩8.25bn₩17.29bn₩3.16bn−₩1.95bn
Total assets₩1.11trn₩1.09trn₩1.06trn₩1.03trn₩1.02trn₩1.01trn₩1.02trn₩999.72bn
Debt₩135.67bn₩128.09bn₩143.76bn₩125.06bn₩128.60bn₩126.83bn₩124.57bn₩131.56bn
Shareholders' equity₩518.99bn₩501.36bn₩488.68bn₩480.74bn₩469.75bn₩458.05bn₩454.68bn₩444.20bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue4.4%5.5%9.0%
Operating income3.4%-1.6%7.3%
Net income8.6%-3.9%6.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin19.9%21.1%23.1%23.6%
Operating margin7.4%8.0%9.4%9.8%
Net margin4.5%3.9%5.6%6.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings5.57.752.111.09.210.712.410.717.015.7
Price to sales0.30.20.50.60.81.00.90.71.11.3

Dividends and splits

Per share, in the currency the company pays

Paid for 36 years. Last went ex-dividend on 29 Dec 2025.

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Paid in the year700.00100.00400.00500.00450.00400.00350.00300.00
  • 2-for-1 split · 17 Apr 2006
  • 5-for-1 split · 13 Apr 1998
  • 1.02-for-1 split · 3 Jan 1998

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.